We are live on ! Find out more
CALA

Calithera Biosciences

Delisted

CALA was delisted on the 1st of February, 2023.

54 hedge funds and large institutions have $86.8M invested in Calithera Biosciences in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more capital inflows, than outflows

Capital inflows: $22.6M | Capital outflows: $5.09M

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

32% more call options, than puts

Call options by funds: $319K | Put options by funds: $241K

11.28% more ownership

Funds ownership: 50.26% → 61.54% (+11%)

10% more funds holding

Funds holding: 49 → 54 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
18
Reduced
9
Closed
9
Calls
$319​K
Puts
$241​K
Net Calls
+$78​K
Net Calls Change
+$149​K

CALA Hedge Fund Activity: Q4 2015 in Review

54 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences (CALA) for Q4 2015, worth a combined $86.8M — up 76% from $49.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CALA positions and 9 closed out — a net gain of 5 holders — while 18 added to existing stakes and 9 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $2.06M. The largest seller was BVF Inc, cutting an estimated $2.16M.

  • 54 institutional investors held Calithera Biosciences (CALA) as of Q4 2015, up from 49 in Q3 2015.
  • Funds reported $86.8M of Calithera Biosciences stock for Q4 2015, up 76% quarter-over-quarter.
  • 14 funds opened new Calithera Biosciences positions in Q4 2015 and 9 closed out, a net change of +5 holders.
  • The largest Calithera Biosciences buyer in Q4 2015 was JP Morgan Chase, an estimated $2.06M added.
  • The largest Calithera Biosciences seller in Q4 2015 was BVF Inc, an estimated $2.16M sold.

Based on aggregated 13F filings for Q4 2015.